All Title Author
Keywords Abstract


Torsadogenic Index: Its Chinese Medical Origin

DOI: 10.4236/pp.2013.47A1001, PP. 1-3

Keywords: T. Index, TCM Principles, Scientific Evidence

Full-Text   Cite this paper   Add to My Lib

Abstract:

The foundational chronology of Torsadogenic Index is introduced to explain the relationship between impending death situations and drug prescription, combination, self-indication, or abuse of torsadogenic pharmacological products. The pathophysiological basis of Torsade de Pointes is presented with the most frequent causes of Long QT syndrome. Traditional Chinese Medical principles are exposed in order to help people to understand its para-logical sequence, providing another view of medical explanations upon scientific evidence. Development of Torsadogenic Risk Management Project and Torsadogenic Traceability concepts derived from these Chinese Medical perpetual axioms are presented in this paper.

References

[1]  A. Inchauspe, “D-Phenylalanine Injection over K-1 Yongquan: A Theoretical Way of Upgrading Survival Rates in CPR,” BIT’s 8th Annual Congress of International Drug Discovery Science and Technology (IDDST), Beijing, 23-26 October 2010.
[2]  J. Wang, “Cardiovascular Safety: How to Develop Risk Assessment,” BIT’s 8th Annual Congress of International Drug Discovery Science and Technology (IDDST), Beijing, 23-26 October 2010
[3]  A. Inchauspe, “Fármaco-Vigilancia y Muerte Súbita,” Jornadas Multidiscipinarias del HINEA y C “Dr. Alejandro Korn”, Melchor Romero, La Plata, 2011.
[4]  F. Desertenne, “La Tachicardie Ventriculaire a Deux Foyers Repposes Veriables,” Archives des Maladies du Coeur et des Vaisseaux, Vol. 59, 1966, pp. 263-272.
[5]  M. Lanzotti and N. Citta, “Síndrome de QT Largo Adquirido: Torsade de Pointes,” Univ. Buenos Aires, Universitá degli Studi de’ll Insubria, 2003. http://www.fac.org.ar/tcvc/llave/c312/lazotti.PDF
[6]  E. Whitsel and P. Rautaharju, “Electrocardiography QT Interval Prolongation and Risk of Primary Cardiac Arrest in Diabetic Patients,” American Diabetes Association, 2005.
[7]  A. Inchauspe, “Torsadogenic Index: A Proposal to Improve Survival Rates in Cardiac Arrests Due to Prescribed Drugs,” Frontiers in Pharmacology, Vol. 3, 2012, p. 99.
http://dx.doi.org/10.3389/fphar.2012.00099
[8]  A. Inchauspe, “Recent Advances in Theories and Practice in Chinese Medicine,” In: Traditional Chinese Medical Criteria about the Use of Yongquan as a Life Support Maneuver, InTech, Croatia, 2011, pp. 362-366. http://dx.doi.org/10.5772/29138
[9]  A. Inchauspe, “Traditional Chinese Medicine and Brain Protection: Can Its Principles Be Consistent with Western Science?” 9th IBIA International Brain Injury Association Congress, Edimburgh, 23-26 March 2012.
[10]  Ling Shu, “Origin and Gathering (Gen Jie),” Chapter 5.
[11]  A. Inchauspe, “Risk Management Project Applied to Torsadogenic Index,” 5th International Conference on Drug Discovery and Therapy, Dubai, 18-21 February 2013.
[12]  A. Inchauspe, “Torsadogenic Index: A Vanguard Risk Management Risk Measure into the Risk Statement Strategy,” Drug Discovery & Therapy World Congress, Boston, 3-6 June 2013.
[13]  D. Iyer, “Optimum Patient Care through Appropiate Drug-Safety Monitoring,” IDDST, 2010.
[14]  J. Kattwinkel and S. Niermeyer, “ILCOR Advisory Statements: Resuscitation of the Newborn Infant. An Advisory Statement from the Pediatric working Group of the International Liaison Committee on Resuscitation,” Circulation, Vol. 99, 1999, pp. 1927-1938. http://dx.doi.org/10.1161/01.CIR.99.14.1927
[15]  N. Swedborg, “Drug Abuse and Dependence Liability Assessment in Safety Pharmacology,” BIT’s 8th Annual Congress of International Drug Discovery Science and Technology (IDDST), Beijing, 23-26 October 2010.
[16]  Ling Shu, “Beginning and Ending (Zhong Zhui),” Chapter 9.
[17]  F. Dessertenne, A. Fabiato and P. Courmel, “Un Chapitre Nouveau Délectrocardiographie: Les Variations Progressives de Lámplitude de L’électrocardiogramme,” Actual Cardio. Angeio. Int, Vol. 15, 1966, pp. 241-258.
[18]  J. López-Valcárcel, “10 Preguntas Frecuentes Sobre el Síndrome del Qt Largo.”
http://www.qtsyndrome.ch/faqsp.html
[19]  B. J. Maron and N. A. Mark Estes III, “Conmotio Cordis,” New England Journal of Medicine, Vol. 362, No. 10, 2010, pp. 917-927. http://dx.doi.org/10.1056/NEJMra0910111
[20]  A. Inchauspe, “Traditional Chinese Medicine K-1 Yongquan and Resuscitation: Another Kind of ‘Lazarus Phenomnon’,” Resuscitation, Vol. 81, No. 4, 2009, pp. 505-506.
http://dx.doi.org/10.1016/j.resuscitation.2009.12.009
[21]  A. Inchauspe, “Sudden, Predictable and Preventable Death in Pharmacological Cardio Safety,” 5th International Conference on Drug Discovery and Therapy, Dubai, 18-21 February 2013.
[22]  M. Ugarte, “Detección precoz de Enfermedades Endócrino-Metabólicas en el Recién Nacido,” Comunidad de Madrid. www.madrid.org

Full-Text

comments powered by Disqus